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ABSTRACT
Background Mitigating the socioeconomic impact 
of tuberculosis (TB) is key to the WHO End TB Strategy. 
However, little known about socioeconomic well- being 
beyond TB- treatment completion. In this mixed- methods 
study, we describe socioeconomic outcomes after TB- 
disease in urban Blantyre, Malawi, and explore pathways 
and barriers to financial recovery.
Methods Adults ≥15 years successfully completing 
treatment for a first episode of pulmonary TB under 
the National TB Control Programme were prospectively 
followed up for 12 months. Socioeconomic, income, 
occupation, health seeking and cost data were collected. 
Determinants and impacts of ongoing financial hardship 
were explored through illness narrative interviews with 
purposively selected participants.
Results 405 participants were recruited from February 
2016 to April 2017. Median age was 35 years (IQR: 28–41), 
67.9% (275/405) were male, and 60.6% (244/405) were 
HIV- positive. Employment and incomes were lowest at TB- 
treatment completion, with limited recovery in the following 
year: fewer people were in paid work (63.0% (232/368) vs 
72.4% (293/405), p=0.006), median incomes were lower 
(US$44.13 (IQR: US$0–US$106.15) vs US$72.20 (IQR: 
US$26.71–US$173.29), p<0.001), and more patients were 
living in poverty (earning <US$1.90/day: 57.7% (211/366) 
vs 41.6% (166/399), p<0.001) 1 year after TB- treatment 
completion compared with before TB- disease onset. Half 
of the participants (50.5%, 184/368) reported ongoing 
dissaving (use of savings, selling assets, borrowing money) 
and 9.5% (35/368) reported school interruptions in the 
year after TB- treatment completion. Twenty- one participants 
completed in- depth interviews. Reported barriers to 
economic recovery included financial insecurity, challenges 
rebuilding business relationships, residual physical morbidity 
and stigma.
Conclusions TB- affected households remain 
economically vulnerable even after TB- treatment 
completion, with limited recovery in income and 
employment, persistent financial strain requiring 
dissaving, and ongoing school interruptions. Measures 
of the economic impact of TB disease should include 
the post- TB period. Interventions to protect the long- 
term health and livelihoods of TB survivors must be 
explored.
INTRODUCTION
An estimated 10 million incident cases of tubercu-
losis (TB) disease occurred globally in 2018, one- 
quarter of which occurred in Africa where 29% of 
patients are HIV coinfected.1 The early costs asso-
ciated with TB disease in low- income settings are 
well recognised: despite provision of free TB- treat-
ment services within the public sector, patients 
incur direct costs related to health seeking, indirect 
costs from lost income, and dissaving (the use of 
savings, borrowing of money, or sale of house-
hold assets) over the course of illness, diagnosis 
and treatment.2 3 These early costs are widespread, 
frequently profound and have been associated with 
adverse TB- treatment outcomes including treat-
ment failure, loss to follow- up or death.4 However, 
Key messages
What is the key question?
 ► What is the lasting socioeconomic impact 
of tuberculosis (TB) disease on patients and 
households: can we assume full economic 
recovery after successful treatment completion, 
and what are the pathways and barriers to this 
recovery?
What is the bottom line?
 ► Many TB- affected households experience a 
limited recovery in income and employment in 
the year after TB- treatment completion, with 
ongoing dissaving and school interruptions. 
Barriers to economic recovery include persistent 
financial insecurity, challenges rebuilding 
business relationships, residual physical 
morbidity and stigma.
Why read on?
 ► The socioeconomic impact of TB disease 
persists well beyond TB- treatment completion. 
Understanding this process, and developing 
strategies to mitigate this, will be crucial if we 
are to meet the WHO End TB Strategy target 
of eliminating TB- related catastrophic costs by 
2030, and improve the long- term well- being of 
TB survivors.
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surprisingly little is known about the lasting economic impact 
of disease beyond TB- treatment completion, and facilitators or 
barriers to economic recovery.
The physical effects of pulmonary- TB (PTB) are felt long 
after treatment completion: mortality rates are three to fourfold 
higher among TB survivors compared with TB- naïve adults,5 TB 
survivors have a high risk of disease recurrence,6 and the burden 
of residual post- TB lung disease (PTLD) is marked.7 8 Limited 
data are available on long- term psychosocial morbidities, but 
reports from TB- affected communities suggest these are consid-
erable.9 10 It is plausible that the ongoing physical and psychoso-
cial impact of TB disease is accompanied by long- term economic 
harm. Understanding this link will be key to improving the 
overall well- being of TB survivors,11 12 and essential if we are 
to meet the WHO End TB Strategy target of eliminating cata-
strophic costs for all TB- affected households by 2030.13
Malawi is one of the poorest countries in the world,14 with an 
estimated national TB incidence of 181/100 000 in 2018.15 In 
this mixed- methods study, nested within a prospective cohort of 
adults successfully treated for PTB in urban Blantyre, Malawi,16 
we describe economic morbidity in the year after TB- treatment 
completion, and explore its determinants and impacts.
METHODS
Full methods of the parent cohort study have been described 
previously.16 In brief, 405 sequential HIV- positive and HIV- 
negative patients successfully completing treatment for PTB 
were recruited between February 2016 and April 2017 in urban 
Blantyre, Malawi. Inclusion criteria were age ≥15 years, and 
successful completion of treatment for a first episode of TB 
as defined by the National TB Control Programme (NTP). We 
excluded patients who had been treated for multidrug resistant 
disease. All participants provided written informed consent.
Study visits were conducted within 1 month of TB- treatment 
completion, and at 6 and 12 months thereafter. Questionnaires 
were completed in the local language, Chichewa. We collected 
data on demographics, socioeconomic situation (SES), TB and 
respiratory symptoms, quality of life, main occupation and 
income at each study visit. Patients provided information on 
occupation and income prior to TB illness from memory. Data on 
ongoing health seeking and associated direct and indirect costs 
were collected prospectively. Occupation was described using 
categories defined by the Malawi Demographic Health Survey 
2015–2016.17 Income and dissaving questions were adapted 
from the STOP TB costing questionnaire.18 Monthly income 
was defined as money received by the individual, from work 
or other means, and was standardised into US dollars (online 
supplemental S1 appendix). Socioeconomic status was defined at 
TB- treatment completion using the Malawi EquityTool 2012.19 
Information on TB microbiology at diagnosis was collected from 
NTP registers. HIV care is provided in a separate programme 
in this setting, and patient- held health passports were there-
fore reviewed to ascertain HIV status and antiretroviral therapy 
(ART) use, with HIV testing offered to all those with unknown 
serostatus who had not had a documented test within the past 
1 month (Serial testing with Determine 1/2; Alere, USA/Uni- 
Gold; Recombigen HIV, Trinity Biotech, Ireland). CD4 counts 
were measured in all HIV- positive participants.
Illness narrative interviews were conducted with purposively 
selected patients who had completed TB treatment ≥12 months 
previously, in order to explore their experiences of TB illness 
and recovery.20 Recruitment ensured variation in gender, HIV 
status and socioeconomic status, and was stopped at the point of 
saturation. Interviews were conducted in Chichewa by a Mala-
wian research assistant in a private location of the participant’s 
choice, most frequently their home, using a predesigned inter-
view guide structured around the illness trajectory (life before, 
during and after TB treatment), which addressed issues of health, 
healthcare seeking behaviour and experiences, socioeconomic 
well- being, family and community life (online supplemental 
S2 appendix). Interviews were audiorecorded, transcribed into 
Chichewa, and translated into English. Notes and observations 
recorded by the study team were included as primary data.
All participants were compensated for their time and travel 
costs, in keeping with local ethics guidelines. The amount 
received over the 1- year study period was the equivalent of 
US$15.30 per participant.
Sample size
The sample size of 400 was predetermined by the parent study, 
in order to allow the prevalence of PTLD to be estimated with 
±5% precision and 95% confidence.
Data analysis
Quantitative data were analysed using Stata V.15 (StataCorp). 
Health economic parameters are presented for each time point 
using median (IQR) values. χ2 test, Fisher’s exact or Wilcoxon 
rank- sum tests were used for comparisons between participant 
groups, and McNemar’s test used for within- group comparisons 
over time. Individuals were classified by occupation into those 
with paid work (self- employed, formally employed (in govern-
ment, non- governmental organisations, private sector), farming, 
domestic work, informal piece- work), unpaid work (housework, 
students) and no work (retired, unemployed). Participants were 
considered to be living in poverty if earning <US$1.90/day.21
Logistic and linear regression models were used to explore the 
relationship between PTLD and economic outcomes, controlling 
for prespecified covariates recorded at TB- treatment completion 
(age, gender, HIV status, TB microbiology, educational level). 
Qualitative data were analysed thematically using an inductive 
framework approach22: transcripts were discussed, a coding 
and thematic framework was developed iteratively, relation-
ships between codes and themes were identified manually, and 
emerging links were cross- checked by discussion with the study 
team and triangulation with study team notes.
RESULTS
Patient population
A total of 450 PTB survivors were screened, and 405 met inclu-
sion criteria (figure 1). The 37/405 (9.1%) participants who did 
not complete the final study visit had similar characteristics (age, 
sex, HIV status, TB microbiology, SES) to those who completed 
the study, but lower average CD4 counts at TB- treatment 
completion (113 cells/µL (IQR: 62–197) vs 244 cells/µL (IQR: 
137–398), p=0.007)(online supplemental S3 appendix).
The majority of participants (67.9% (275/405)) were male, 
77.3% (313/405) had microbiologically proven PTB disease, 
and 60.6% (244/403) were HIV- positive. Over half were from 
the lowest three urban wealth quintiles (54.3% (202/372)) and 
38.0% (154/405) had not attended school beyond primary level. 
The 21 participants purposively selected for in- depth interviews 
had similar demographic and socioeconomic characteristics to 
other study participants, but a longer duration of illness prior 
to TB treatment (13.0 vs 8.7 weeks, p<0.001), and less formal 
education (38.1 (8/21) vs 63.3% (243/384) beyond primary 
school, p=0.021) (table 1).
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Economic morbidity, after TB-treatment completion
Occupation and income
The proportion of participants in paid work fell during TB disease 
to a nadir of 54.8% (222/405) at TB- treatment completion, with 
36.5% (148/405) unemployment (National unemployment rates 
5.4%–5.7% between 2016 and 2018).23 One year later, fewer 
participants were in paid work than prior to disease (63.0% 
(232/368) vs 72.4% (293/405), p=0.003), and the proportion 
of self- employed business people had not returned to previous 
levels (preillness: 32.8% (133/405); TB treatment end 26.9% 
(109/405); 1- year post- treatment completion 25.8% (95/368), 
p=0.026). Patterns were similar for HIV- positive and negative 
participants (figure 2).
A fifth of participants (20.7%, 74/358) moved from paid or 
unpaid work prior to TB disease, to no work by 1 year after 
TB- treatment completion. Half of these individuals lost work 
during TB disease and treatment (47.3%, 35/74), and half lost 
work in the year after treatment completion (52.7%, 39/74). 
Loss of work was more common in the lowest two versus 
highest three socioeconomic quintiles (28.6% (30/105) vs 15.9% 
(39/245), p=0.004). Among those who were employed prior to 
disease, 11.0% (17/154) had become self- employed by the end 
of follow- up.
Many participants did not know their total household 
income, including 40.7% (53/130) of women. However, indi-
vidual incomes followed a similar pattern to that seen with 
work: median income was highest prior to TB illness, falling to 
a nadir at TB- treatment completion, with minimal recovery in 
the following year (figure 3). Monthly incomes fell by a median 
of $11.59 (IQR for income difference: −72.20 to +12.89) 
Figure 1 Participant flow diagram. TB, tuberculosis.
Table 1 Participant characteristics for participants included/ not included in nested qualitative work
Participant characteristic Parent study only (n=384) Parent and qualitative study (n=21) p- value*
Age (years) (median, IQR) 34 (28–41) 35 (32–41) 0.246
Male sex (n, %) 261 (68.0%) 14 (66.7%) 0.901
Positive TB microbiology† at diagnosis (n, %) 299 (77.9%) 14 (66.7%) 0.233
Self- reported illness duration prior to TB treatment (weeks) (median, IQR) 8.7 (4.3–13.0) 13.0 (13.0–52.2) <0.001
HIV- infected at TB- treatment completion (n=403)‡ 232 (60.7) 12 (57.1) 0.743
ART use at TB- treatment completion (n, %) (n=244) 215 (92.7) 9 (75.0) 0.030
CD4 if HIV- positive at TB- treatment completion (cells/µL) (median, IQR) (n=242) 229 (127-397) 214 (126–420) 0.941
Maximum education level >primary school (n, %) 243 (63.3%) 8 (38.1%) 0.021
Urban SES quintile (n, %) (n=372) §
 ► Poorest
 ► Second poorest
 ► Middle
 ► Second most wealthy












*χ2 test for categorical variables, Wilcoxon rank- sum test for continuous variables.
†Microbiology positive if smear, culture or Xpert MTB/RIF positive.
‡HIV status missing for two study participants.
§ Urban household wealth quintiles calculated from household characteristic and asset data, using a tool validated by the Malawi Malaria Indicator Survey 2012 (Equity 
measurement Toolkit; Social Franchising Metrics Working Group)19
ART, antiretroviral treatment; SES, socioeconomic situation; TB, tuberculosis.
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from pre- illness to 1- year post treatment completion, with the 
greatest loss among those who were originally self- employed (−
US$74.96 (IQR: −231.99 to −7.01)). There was little differ-
ence in the median income loss experienced by the poorest 
two and wealthiest three socioeconomic quintiles over this 
period (−US$11.78 (IQR: −56.73 to +16.63) vs −US$10.77 
(IQR:−77.23 to +11.60), p=0.556).
The proportion of participants living in poverty increased from 
41.6% (166/399) to 57.7% (211/366) over this time (p<0.001), 
but the proportion of participants reporting that they were the 
highest earner in the household did not change (pre- illness: 
57.0% (231/405); TB- treatment end 54.6% (221/405); 1- year 
post treatment completion 60.6% (223/368)).
Healthcare costs
Direct healthcare costs in the year after TB- treatment comple-
tion were limited. Among those contributing any follow- up data, 
two- thirds of participants (66.8%, 254/380) had ≥1 outpatient 
visit, including 264 planned and 173 unscheduled visits, and 
6.3% (24/380) had ≥1 inpatient admission. The majority of 
both outpatient visits (95.0%, 415/437) and admissions (88.9%, 
24/27) occurred within the public sector. The majority of planned 
visits (87.1%, 230/264) were for appointments at ART clinics.
The median direct cost of an outpatient visit, including both 
planned and unscheduled visits, was US$1.05 (IQR: 0.14–2.09), 
including expenditure for clinic fees and medications, and 
travel, accommodation, food and phone time for patients and 
guardians. The median time taken for any outpatient visit was 
3 hours (IQR: 2–4), and loss of income was reported for 53.1% 
(232/437) of these visits, with average income time loss of 1 hour 
(IQR: 0–1) only. Guardians attended with study participants for 
a minority (8.2%, 36/437) of outpatient visits, and on these 
occasions rarely reported income time lost (5.6%, 2/36).
The median duration of the 27 inpatient admissions was 
four nights (IQR: 2–19), with median direct costs of US$19.62 
(IQR 13.30–61.91). Lost income was reported by participants 
for under a third of admissions (29.6%, 8/27), and although 
participants were accompanied by a guardian for the majority 
of these admissions (88.9%, 24/27) only one guardian reported 
lost income.
The proportion of participants attending ≥1 outpatient visit 
was similar in the lowest two, and top three socioeconomic 
quintiles (66.2% (73/107) vs 66.8% (177/265), p=0.790), and 
median per- visit costs were similar between socioeconomic 
groups (US$0.84 vs US$1.12, p=0.578). A higher proportion 
of participants from the lowest two socioeconomic quintiles 
required hospital admission compared with the top three quin-
tiles (10.3% (11/107) vs 4.9% (13/265), p=0.056) but median 
per- admission costs were similar between groups (US$19.27 vs 
US$19.97, p=0.750).
Impact of economic morbidity, on patients and households
Interruption of a child’s schooling due to the financial impact of 
illness was reported by 17.0% (69/405) and 9.5% (35/368) of 
TB- affected households in the years prior to and after TB- treat-
ment completion, respectively. School interruptions were more 
common in the lowest two, compared with the top three, 
socioeconomic quintiles (32.1% (34/106) vs 17.7% (45/255), 
p=0.003).
Over a third of participants (37.0%, 150/405) reported 
that TB had had a severe financial impact on their household, 
graded ≥4/5 on a Likert scale, at TB- treatment completion. This 
proportion was 16.9% (62/368) 1 year later. Self- reported severe 
financial impact was more common in the lower socioeconomic 
strata (58.5% (62/106) vs 37.4% (96/257), p<0.001).
Figure 2 Self- reported occupation over time (prior to TB disease, at TB- treatment completion and 1- year after TB- treatment completion) stratified by 
HIV status. 
*HIV status available for 403 participants; ˆAd hoc work (eg, washing clothes, driving of minibuses, carrying goods for others). TB, tuberculosis.
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Almost three- quarters of participants reported dissaving 
by the point of TB- treatment completion (73.6%, 298/405), 
and half reported dissaving in the following year (50.5%, 
186/368), at values of 54.9% (IQR:24.3%–146.4%) and 53.2% 
(IQR:19.0%–125.7%) of the baseline monthly income prior to 
TB illness respectively. Over a quarter (26.7%, 27/101) of those 
with no dissaving during TB disease and treatment did go on to 
report dissaving in the year after treatment completion. Dissa-
ving was more common in lower SES quintiles, but with lower 
absolute and relative values (table 2).
Patterns of dissaving varied by SES group, and over time 
(figure 4). All wealth strata used savings during the period of 
TB illness and treatment, but only the wealthiest quintiles used 
savings during the subsequent year. Borrowing money was the 
most common among lower socioeconomic strata, and over half 
of those in the lowest quintiles reported borrowing money in the 
year after TB- treatment completion. The most common sources 
of borrowed money were friends (44.8%, 172/384), family 
(26.8%, 103/384) and the black market (10.2%, 39/348)—use 
of the latter increased from 10.7% (19/177) in the first year to 
17.1% (25/246) in the second year. The sale of assets to cover 
costs due to illness during the period of TB illness and treatment 
was also more common in poorer groups. The most common 
items sold were household items (35.0%, 134/383) and mobile 
phones (10.7%, 41/383). Potentially income- generating assets 
sold included land (1.3%, 5/383), livestock (3.7%, 14/383) and 
means of transport (4.7%, 18/383).
Relationship with TB retreatment
TB retreatment was initiated in 15/405 (3.7%) of participants, 
of whom five died, one relocated, and nine completed study 
follow- up. Socioeconomic outcomes were poor among those who 
survived and completed follow- up: by 1 year after TB- treatment 
completion, a higher proportion of those receiving retreatment 
had lost work (33.3% (3/9) vs 20.3% (71/349), p=0.342), expe-
rienced dissaving (100% (9/9) vs 79.4% (285/359), p=0.128), 
or reported a severe financial impact from TB disease (33.3% 
(3/9) vs 16.4% (59/359), p=0.181), compared with those who 
did not receive retreatment. However, none of these differences 
were statistically significant.
Relationship between physical and economic morbidity
Almost one- third of participants had abnormal spirometry 
(30.7%, 103/336) or regular respiratory symptoms (30.7%, 
113/368) 1 year after TB- treatment completion. Those with 
abnormal spirometry were more likely to have lost work in the 
period from TB- illness onset, compared with those with normal 
Figure 3 Self- reported income over time (prior to TB disease, at 
TB- treatment completion and 1- year after TB- treatment completion) 
stratified by HIV status (median, IQR)#.*Income data recorded in 
Malawian Kwacha with standardisation into US dollars by exchange 
rate at midpoint of pre- TB, baseline, and 1- year data collection intervals 
(online supplemental S1 appendix). #HIV status available for 403 
participants. TB, tuberculosis
Table 2 Prevalence and value of dissaving in the years prior to and after TB- treatment completion, stratified by wealth quintiles*
Time period
Malawi urban wealth quintile (Q1–Q5)†
All participants
Q1 (n=56)
Wealthiest Q2 (n=114) Q3 (n=95) Q4 (n=85)
Q5 (n=22)
Poorest
Prior to TB illness (n=372)
  Predisease monthly income (US$) 108.30 (0–270.76) 83.03 (39.71–287.73) 63.18 (25.27–158.84) 61.37 (25.27–111.91) 41.52 (10.83–121.30) 72.20 (25.27–173.29)
During TB illness and treatment (n=372)
  Proportion incurring any dissaving 28/56 (50.0%) 83/114 (72.8%) 75/95 (79.0%) 68/85 (80.0%) 20/22 (90.9%) 274/372 (73.7%)
  Value of dissaving, if experienced (US$)‡ 166.9 (94.58–423.50) 69.54 (34.77–173.85) 38.94 (15.30–115.44) 27.82 (16.69–80.95) 33.38 (13.91–100.39) 55.63 (20.86–139.08)
  % of predisease monthly income 
(median, IQR)
89.2% (34.1–266.0) 58.2% (24.1–152.3) 53.9% (20.7–111.2) 41.6% (23.4–104.6) 44.1% (35.0–173.4) 54.9% (24.3–146.4)
Year after TB- treatment completion (n=360)
  Proportion incurring any dissaving 12/55 (21.8%) 48/107 (44.9%) 61/92 (66.3%) 50/84 (59.5%) 13/22 (59.1%) 184/360 (51.1%)
  Value of dissaving, if experienced (US$)‡ 167.6 (59.36–272.35) 69.83 (24.1–152.3) 39.11 (20.95–92.18) 37.71 (13.97–69.83) 20.95 (11.17–31.42) 41.9 (20.95–94.97)
  % of predisease monthly income 
(median, IQR)
112.5% (49.0–232.1) 77.6% (19.0–198.7) 59.3% (24.2–89.3) 41.9% (13.6–120.7) 29% (15.0–58.0) 53.2% (19.0–125.7)
*Values given for those who experienced dissaving, only.
†Baseline SES missing for 33 participants—data included for 372 participants only.
‡Standardisation into US$ using exchange rates at midpoints of first and last study visits.
SES, socioeconomic situation; TB, tuberculosis.
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spirometry (OR 1.87, 95% CI 1.02 to 3.41). Those with residual 
symptoms were more likely to report that TB had had a severe 
financial impact on the household, compared with those without 
symptoms (2.02, 95% CI 1.10 to 3.68). Those with chest symp-
toms limiting their ability to keep up with peers (17.4%, 64/368), 
interfering with work (12.2%, 45/368) or limiting activities 
(4.4%, 16/368) at 1 year were significantly more likely to have 
experienced both of these outcomes. No significant association 
was observed between these measures of physical morbidity 
and the use of dissaving or change in income from pre illness to 
1- year post TB- treatment completion (table 3).
Illness narratives
The persistent socioeconomic impact of TB disease was evident 
in the illness narrative data (table 4). The shift to a lower stan-
dard of living after TB disease was raised as a barrier to ongoing 
health and well- being. The need for further dissaving and with-
drawal of children from school to release extra funds were high-
lighted as areas of concern.
Anxiety around loss of financial security, debt and the chal-
lenge of ongoing dependence on family and friends for support 
emerged as strong themes. A gendered response was seen with a 
perceived loss of social standing due to this dependence particu-
larly common and problematic for men.
Reasons for limited recovery of income and work were 
explored. Ongoing physical morbidity was noted as a challenge 
to patients’ livelihoods, however, participants largely continued 
to work despite residual symptoms in order to maintain income. 
Stigma was widely experienced and resulted in delayed return 
to work, or loss of work for those previously employed, with 
discrimination from colleagues often rooted in the perception 
that TB and HIV disease are linked. Loss of business infrastruc-
ture and the lack of capital to rebuild and reinvest was high-
lighted. Participants reported challenges in rebuilding business 
relationships which had been lost after a prolonged absence 
during the illness period, including those with employers, 
employees and customers.
DISCUSSION
In this study, we explore the long- term socioeconomic conse-
quences of TB disease after TB- treatment completion. Our data 
show that the substantial financial insult experienced during 
TB illness extends to 12 months post- treatment completion. 
Economic recovery in the year after TB- treatment was slow and 
incomplete, with many patients continuing to experience income 
loss and reduced work. Persistent dissaving was widely observed 
and suggests increasing financial vulnerability. A substantial 
minority of patients experienced ongoing respiratory morbidity 
after treatment completion, and this was significantly associated 
with economic morbidity. Additional barriers to recovery after 
TB- treatment completion included ongoing financial insecurity 
from initial TB disease, reduced social capital and TB- related 
stigma.
Even in settings where TB services are free of charge within 
the public sector, the financial impact of TB disease is marked: 
a 2014 systematic review of 49 studies found that on average 
Figure 4 Proportion of participants incurring patterns of dissaving, during TB illness and treatment (n=372), and in the year after TB- treatment 
completion (n=360), stratified by urban wealth quintile (Q1–Q5)*. 
 Q1 – Q5: richest to poorest urban wealth quintiles, calculated at TB treatment completion using the MalawiEquityTool 2012.  
*Wealth quintile data missing for n=33 participants. 
TB, tuberculosis.
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patients lost the equivalent of 58% (range 5%–306%) of annual 
individual income and 39% (range 4%–148%) of annual house-
hold income in direct and indirect costs during TB illness and 
treatment, with half of all costs incurred prior to treatment initi-
ation.3 Those incurring ‘catastrophic’ costs (≥20% of annual 
household income) have been shown to have higher odds of 
adverse TB- treatment outcomes (death, treatment failure or 
recurrence).4
Our results support these findings of a major initial TB- related 
financial insult: during TB disease and treatment employment 
decreased, average patient incomes fell, and three- quarters of the 
cohort incurred dissaving. This pattern was seen across socioeco-
nomic and employment groups, and by the end of TB- treatment 
the majority of TB survivors were living in poverty.
However, our data also show that this impact is sustained, 
even after TB- treatment completion. Although the proportion 
of participants working increased in the year after TB- treat-
ment completion, it did not return to baseline: 1 year after TB 
treatment, almost one- third of patients were unemployed, with 
standardised individual incomes lower than prior to illness. Self- 
employed individuals appeared particularly vulnerable, with 
large drops in income experienced by both those who were 
in work through their disease, as well as those who stopped 
working.
Post- TB physical morbidity was associated with limited 
recovery: abnormal spirometry, ongoing respiratory symptoms 
and chest symptoms limiting activity at 1 year were strongly 
associated with loss of work and perceived financial severity of 
the TB illness episode in multivariate analyses. Post- TB physical 
morbidity is increasingly recognised as a key component of the 
overall number of disability- adjusted and quality- adjusted life- 
years lost in relation to TB disease,24 and our findings suggest 
that its impact on long- term productivity and financial vulnera-
bility should also be considered.25 Recurrent TB disease may also 
be detrimental to this group: socioeconomic outcomes among 
those receiving TB retreatment were poor in this study, but our 
ability to explore this finding was limited by the low numbers 
of retreatment patients identified, and further work is needed 
in this area.
In- depth interviews highlighted the loss of business assets 
during disease, with limited access to capital to rebuild after 
treatment completion as a major barrier to recovery. The chal-
lenge of rebuilding relationships with employers, employees and 
clients was emphasised, and attributed to a prolonged period 
of absence during TB illness and treatment, as well as loss of 
social standing due to impoverishment, disability, and the direct 
consequences of TB- related and HIV- related stigma. The impact 
of TB- related stigma on patients’ emotional well- being has been 
documented elsewhere,26 but our data suggest that this also has 
socioeconomic repercussions.
Rather than promptly recovering, our data suggest that many 
TB survivors are at risk of further financial and psychological 
decline after TB- treatment completion. Dissaving is a coping 
mechanism for catastrophic costs,2 and has been widely observed 
in TB- affected households during TB illness and treatment.27 
However, in this study, dissaving was observed in half of the 
cohort in the year after TB- treatment completion, including 
several households who had resisted dissaving during initial 
disease and treatment itself. Concern about dissaving was widely 
reported in the qualitative data. These findings suggest that even 
after TB- treatment completion, households continue to deplete 
their reserves or enter into further debt as they struggle to cover 
costs or seek to rebuild their lives and livelihoods.
Of particular concern, both the use of savings and the sale 
of assets declined in the post- treatment period, particularly 
among low socioeconomic strata, perhaps reflecting depletion 
of these resources. Instead, borrowing of money remained wide-
spread with increasing use of the black market for loans, perhaps 
Table 3 Adjusted ORs for associations between respiratory morbidity at 1- year post treatment completion, and economic outcomes over the 
study period, in multivariate analyses controlling for patient characteristics (age, gender, HIV status, TB microbiology, and educational level) at TB 
treatment completion
Physical morbidity
Economic outcome from prior to TB illness, to 1- year post- treatment completion
Loss of work (OR, 
95% CI)




Self reported severe financial 
impact of TB at 1 year (OR, 95% CI)




1.87 (1.02 to 3.41)
1.0
1.31 (0.71 to 2.43)
11.64 (–50.80 to 74.09) 1.0
1.85 (0.96 to 3.58)
p=0.042 p=0.393 p=0.714 p=0.066




1.26 (0.72 to 2.20)
1.0
0.79 (0.45 to 1.37)
−6.34 (–63.01 to 50.33) 1.0
2.02 (1.10 to 3.68)
p=0.412 p=0.399 p=0.826 p=0.022
Difficulty keeping up with peers when 




2.39 (1.27 to 4.49)
1.0
0.61 (0.32 to 1.18)
7.26 (–62.80 to 77.31) 1.0
2.04 (1.03 to 4.04)
p=0.007 p=0.145 p=0.839 p=0.041
Chest symptoms interfering with/stopping 




4.13 (2.06 to 8.28)
1.0
1.04 (0.45 to 2.39)
32.73 (–47.09 to 112.56) 1.0
4.24 (2.08 to 8.66)
p<0.001 p=0.934 p=0.421 p<0.001
Chest symptoms limiting most/all daily 




9.35 (3.02 to 28.95)
1.0
0.56 (0.17 to 1.85)
12.51 (–118/28 to 143.29) 1.0
11.82 (3.74 to 37.33)
p<0.001 p=0.340 p=0.851 p<0.001
Income difference: US$ standardised change in monthly income from prior to TB disease, to 1- year post- TB- treatment completion.
Use of dissaving: any use of savings, borrowing of money or selling of assets from the onset of TB disease to 1- year post TB- treatment completion.
Loss of work: no longer working, having been in work (employed or self- employed) prior to TB disease.
TB, tuberculosis.
7Meghji J, et al. Thorax 2020;0:1–10. doi:10.1136/thoraxjnl-2020-215338













reflecting the exhaustion of more ‘benign’ sources of loans such 
as friends and family.
Interruption of children’s education continued in 10% of 
households in the year after TB- treatment completion, and a 
high burden of anxiety related to financial insecurity, lower stan-
dard of living, and school interruptions was observed among TB 
survivors. Men voiced concern around loss of social standing, 
which is consistent with previous work describing high societal 
pressures on men to be effective providers, regardless of the 
difficulties of their circumstances.28 Taken together, our qual-
itative and quantitative data suggest that TB disease may push 
patients into an ongoing cycle of poverty, with many patients 
become increasingly financially vulnerable after TB- treatment 
completion, rather than experiencing financial recovery.
This study was performed at a single site and work from 
other resource- limited settings is needed to confirm findings. 
In the absence of a control group we cannot exclude the possi-
bility that changes observed were related to general changes 
in the economy, although this is unlikely as unemployment 
within Malawi was falling over the study period, changes 
in income persisted despite time- dependant standardisation 
into USD, and findings were consistent across qualitative and 
quantitative data.23 Data on incomes and occupation prior 
to TB- illness onset, and healthcare costs between study visits 
Table 4 Quotes from in- depth interviews with TB survivors
Theme Quote
Impact of TB- related financial hardship on participants and households
Reduced standard of living ‘Since the time I was diagnosed with TB until now, I am staying in a bad looking house, with bad sleeping environment along with bad food’ (female 
participant, 39 yrs 
‘As [name of participant] hasn’t been able to find work since he completed his treatment, the family had to move up the hill, where housing is cheaper. 
They also had to sell most of their furniture. There was only a mat on the floor, a little stool and a couple of mugs for a family of four…Another interesting 
observation we made relates to his relocation. Moving to cheaper accommodation on top of the hill means that he leaves the house less, as physical 
exercise remains a big challenge for him. This in turn limits his occupational activities and affects his health seeking behavior’ (Research Assistant, relating 
to male participant, 32 yrs)
Anxiety around debt and 
financial insecurity
‘I never used to have financial difficulties. Now, my business is just so small with borrowed capital and the creditors keep coming to my house, saying they 
want their money. If I fail to pay, there will be bigger interest. I have been in debts ever since I completed the treatment’(female participant, 29 yrs)
 
‘Now, I am not having anything to eat and sometimes I don’t have money to pay for rent. For example, I haven’t paid rent yet. In the past, before I became 
sick, I could pay rent in advance’ (male participant, 34 yrs)
‘I have been facing financial challenges, lack of food and so on. In 2016, my girl failed to write her form two exams, due to lack of schooling that I couldn’t 
pay for. So, I have faced so many difficulties from the time that I was diagnosed with TB until now’ (female participant, 39 yrs)
‘I used to sell our house equipment to sustain my family. So, we sold our TV and some small items. Others who could help us were living far from us and 
they can’t just be helping you every day. Our children stopped going to school, so we had to sell whatever household equipment we had to sustain our 
living’ (male participant, 32 yrs)
Dependence on others ‘As of now, I have difficulties to get food, but I do try my level best to hunt for money to buy the food. My family supports me since I’ve completed 
treatment. Whenever I say that I don’t have money to pay rental expenses and to buy food, they do send me the money’ (female participant, 27 yrs)
Loss of social standing ‘While I was sick and during the time when I completed my treatment people were not respecting me, but people were respecting me before I became 
unwell with TB. I think this is because I lost my income, and my family helps me. When you have money, people tend to respect you’ (male participant, 34 
yrs)
‘He feels, once you have money, you have so much power and you can tell your employees what to do. In his case, his employees overtook power while he 
got sick, which still affects him’ (Research Assistant, relating to a male participant, 34 yrs)
When asked about how the income loss affects life: ‘It has affected me a lot. I just feel depressed and sometimes I wonder if I am the same person’. (male 
participant, 18 yrs)
Barriers to income recovery
Ongoing physical morbidity ‘There are so many problems, I am facing these days because everything needs money… I still need to work, so I do some piece work, whether it means that 
I am still feeling pain, but I do work in order to get money to help myself…. The most important thing is to get money, so if you don’t work then you have to 
do business in order to maintain your health and to fulfil your needs’ (male participant, 37 yrs)
Stigma ‘My boss said that I should wait at home during treatment…My boss accepted my TB diagnosis, but she didn’t want me back after I completed’ (female 
participant, 42 yrs)
‘I went back to my work, but my boss discriminated against me and he told me that he wouldn’t be helping me anymore financially, so I am just staying 
here at home’ (male participant, 32 yrs)
‘They [colleagues] would be surprised to see my work performance, which was dropping as I could sometimes work well one day and sometimes, I could not 
work well …they were saying that it was AIDS’ (male participant, 18 yrs)
‘The wife of the participant told us that she sells food items in front of the house and noted that some people don’t want to buy from her, because they 
know that her husband is sick’ (Research Assistant, relating to male participant, 32 yrs)
Loss of social and work 
relationships
‘Our customers really had forgotten us, so I think it will take time for me to grow the business again’ (male participant, 33 yrs)
Lack of capital for reinvestment ‘My life has changed now …I have little capital … I don’t do hard work now, so my employees help me do business. My business isn’t the way it was 
before, because some of my business centers are closed now, I stopped selling Irish potatoes, I closed my take- away shops and I only have one bench of 
chips’ (male participant, 48 yrs)
‘The TB symptoms affected my business so much, to the extent that it went down up to date and it’s not at all growing, though I was cured…My husband 
cannot even afford to give me MK 20,000.00 to start up a new business. I went to borrow money from someone on interest, but I haven’t paid the person 
back. The capital you have determines what kind of business one engages in. So, instead of starting up a business with the little money borrowed, you start 
buying maize to feed children at home’ (female participant, 39 yrs)
TB, tuberculosis.
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were collected retrospectively, with some risk of recall bias. 
Our analyses used individual rather than household- level 
income data, perhaps leading us to underestimate participants’ 
access to financial resources. The financial compensation 
provided for study participation may have acted as an addi-
tional source of income, cushioning participants from the full 
financial hardship which may have been experienced under 
routine conditions.
Strengths of this study include its novel focus on patients’ lives 
and livelihoods after TB- treatment completion, and use of mixed 
methods to understand participant perspectives and experiences. 
Qualitative data were collected to saturation, and the economic tools 
used were derived from validated sources. The study was conducted 
in an unselected population, with broad inclusion criteria, and 
minimal loss to follow- up, allowing broad generalisability.
Our findings have several key implications for TB research, 
policy and programmes. We recommend that studies investi-
gating costs associated with TB disease should measure economic 
outcomes beyond TB- treatment completion. Recent data suggest 
that mortality rates among TB survivors are higher than that of 
TB- naïve individuals, and the extent to which the socioeconomic 
impact of TB disease contributes to this requires further inves-
tigation. Our findings suggest that interventions to protect live-
lihoods and prevent dissaving during disease may be crucial to 
the long- term well- being of TB- affected households. Microloans 
and training programmes to assist TB survivors to rebuild their 
livelihoods after treatment completion must be explored. These 
interventions should be codeveloped with TB- affected commu-
nities, and must be accompanied by community- level education 
programmes to address TB- related stigma. Ultimately, a renewed 
focus on physical, psychological and socioeconomic well- being 
after TB- treatment completion is needed if we are to improve 
the long- term outcomes of TB survivors.
Twitter Elizabeth L Corbett @LizCorbett17
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